07.12.2025, 1501 Zeichen

Week 49 brought new records in Vienna with a small correction on friday. News came from Uniqa, Austrian Post, Verbund, Agrana, VIG and Porr. 

BSNgine weekly Spitout: The ATX TR up 1,44% to 12.394,1 points this week. Year-to-date the ATX TR is now at 45,18%. Up to now there were 131 days with a positive and 108 with a negative gain. From the year-high we are 0,2% away, from the low 46,14%. Statistically the best weekday so far 2025 is Thursday with 0,33%, the weakest is Friday with -0,11%.

These are the best-performers this week: FACC 7,3% in front of Porr 6,26% and RHI Magnesita 5,02%. And the following stocks performed worst: Pierer Mobility -8,13% in front of CPI Europe AG -3,9% and Telekom Austria -3,48%.

Further highlights this week: Andritz for 3 days in a row up (5,17% gain from 61,9 to 65,1), also SBO 3 days up (3,77% gain from 27,85 to 28,9).

Best-performers year-to-date as of now: AT&S 164,24% (last year: -53,95 percent) followed by Frequentis 151,08% (last year: 1,83 percent) and voestalpine 106,44% (last year: -35,82 percent). And the worst-performing stocks year-to-date: Zumtobel -26,22% (Vorjahr: -21,97 percent), followed by RHI Magnesita -25,06% (Vorjahr: -1,26 percent) and Lenzing -18,64% (Vorjahr: -17,02 percent).

High above the MA200: AT&S 59,87%, FACC 46,55% and voestalpine 41,19%.
Down under the MA200: Zumtobel -17,67%, CPI Europe AG -14,47% and Kapsch TrafficCom -13,24%.

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (06/12/2025)

Christian Drastil: Wiener Börse Plausch

BörseGeschichte Podcast: Christian-Hendrik Knappe vor 10 Jahren zum ATX-25er

Bildnachweis

Aktien auf dem Radar:DO&CO, Amag, AT&S, Austriacard Holdings AG, RHI Magnesita, SBO, Rosgix, Rosenbauer, FACC, Lenzing, OMV, Polytec Group, Zumtobel, Porr, Frequentis, Gurktaler AG Stamm, Wienerberger, Wolford, Wolftank-Adisa, Palfinger, Pierer Mobility, EuroTeleSites AG, Oberbank AG Stamm, BKS Bank Stamm, Marinomed Biotech, Österreichische Post, Verbund, GEA Group, Bayer, Fresenius Medical Care, Symrise.

---